Concepedia

Publication | Closed Access

Benefits of Semelil (ANGIPARSTM) on oxidant-antioxidant balance in diabetic patients; A randomized, double-blind placebo controlled clinical trial

10

Citations

20

References

2015

Year

Mahboobeh Hemmatabadi, Mohammad Abdollahı, S Bakhshayeshi, Ramin Heshmat, Maryam Baeeri, Omid Azimaraghi, Bagher Larijani
DARU Journal of Pharmaceutical Sciences

References

YearCitations

Page 1